Baxter Corporation

Industry:	Pharmaceuticals, Drug Manufacturing & Research, Medical Devices & Equipment
Revenues:	$123.1 Million
Employees:	15,176

Description

For over 50 years, Baxter has been a leader in the biotechnology industry and a pioneer in developing critical therapies to treat chronic diseases. Baxter is a leading producer of both plasma-based and recombinant clotting factors for hemophilia, as well as biopharmaceuticals used to treat immune deficiencies and other blood-related disorders. Baxter also produces vaccines for the prevention of infectious diseases, as well as biosurgery products used for hemostasis and tissue-sealing in surgery. Baxter's breadth and depth of expertise in recombinant protein manufacturing, plasma fractionation and proprietary Vero-cell vaccine manufacturing technologies set it apart from other companies in these fields.

Products & Services

specialty pharmaceuticals, drug, therapies, portfolio, clotting factors

Find More Jobs

Job Openings

Physician - Pulmonary Disease - Critical Care , AR

Physician - Urology , AR

Medical Director Round Lake , IL

Microbiology Research Associate III - Sterilization Round Lake , IL

Sr. Quality Manager - Product Surveillance Round Lake , IL

News Archive

Baxter Hosts 2009 Investor Conference.(Conference news) Business Wire; 9/16/2009 Baxter Highlights Focus On Innovation And Value...its Investor Conference today in Chicago, Baxter International Inc. (NYSE:BAX) will...focus on innovation and value creation. Baxter's diversified business model, medically... ...more

Baxter Highlights Progress Toward Sustainability Priorities in 10th Annual Sustainability Report.(Report) The Business of Global Warming; 7/6/2009 Baxter International Inc. (NYSE: BAX) released...areas," said Robert L. Parkinson, Jr., Baxter's chairman and chief executive officer...products and therapies for patients." Baxter's sustainability priorities, grouped... ...more

Baxter Receives European Commission Approval for CELVAPAN H1N1 Pandemic Influenza Vaccine. Business Wire; 10/7/2009 DEERFIELD, Ill. -- Baxter International Inc. (NYSE: BAX) today...CELVAPAN H1N1 pandemic vaccine using Baxter's Vero cell technology. CELVAPAN...authorization in the European Union. Baxter continues to deliver vaccine to national... ...more